_id
691718ff3c536f8df23164e5
Ticker
STOK
Name
Stoke Therapeutics Inc
Exchange
NASDAQ
Address
45 Wiggins Avenue, Bedford, MA, United States, 01730
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.stoketherapeutics.com
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy; and Zorevunersen (STK-001), an investigational new medicine for the treatment of Dravet syndrome is being evaluated in phase I/II clinical trials. The company also develops programs focused on various targets, including haploinsufficiency diseases of the central nervous system and eye. It has a license and collaboration with Biogen Inc. for the development and commercialization of zorevunersen medicine for the treatment of Dravet syndrome; and Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of genetic neurodevelopmental diseases. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.
Last Close
33.09
Volume
663037
Current Price
32.39
Change
-2.1154427319431934
Last Updated
2025-12-04T13:39:51.528Z
Image
data:image/webp;base64,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
Ipo Date
2019-06-19T00:00:00.000Z
Market Cap
1768347008
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9892636363636363
Sentiment Sources
11
Rating
4.6
Target Price
31.625
Strong Buy
7
Buy
2
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
10632000
Cost Of Revenue
989000
Gross Profit
9643000
Operating Expenses
52734000
Operating Income
-43091000
Interest Expense
3000
Pretax Income
-39625000
Net Income
-38347000
Eps
-0.6542552945550424
Dividends Per Share
-
Shares Outstanding
57117150
Income Tax Expense
-1278000
EBITDA
-38633000
Operating Margin
-405.2953348382243
Total Other Income Expense Net
3466000
Cash
83394000
Short Term Investments
164916000
Receivables
10837000
Inventories
-
Total Current Assets
272437000
Property Plant Equipment
6791000
Total Assets
360264000
Payables
5871000
Short Term Debt
2908000
Long Term Debt
-
Total Liabilities
52159000
Equity
308105000
Depreciation
989000
Change In Working Capital
-1119000
Cash From Operations
-30366000
Capital Expenditures
132000
Cash From Investing
9094000
Cash From Financing
3120000
Net Change In Cash
-18153000
PE
43.6056
PB
6.161640408399734
ROE
-12.44608169292936
ROA
-10.644138742699798
FCF
-30498000
Fcf Percent
-2.868510158013544
Piotroski FScore
1
Health Score
27
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
6.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
10632000
Quarters > 0 > income Statement > cost Of Revenue
989000
Quarters > 0 > income Statement > gross Profit
9643000
Quarters > 0 > income Statement > operating Expenses
52734000
Quarters > 0 > income Statement > operating Income
-43091000
Quarters > 0 > income Statement > interest Expense
3000
Quarters > 0 > income Statement > pretax Income
-39625000
Quarters > 0 > income Statement > net Income
-38347000
Quarters > 0 > income Statement > eps
-0.6542552945550424
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
58611677
Quarters > 0 > income Statement > income Tax Expense
-1278000
Quarters > 0 > income Statement > EBITDA
-38633000
Quarters > 0 > income Statement > operating Margin
-405.2953348382243
Quarters > 0 > income Statement > total Other Income Expense Net
3466000
Quarters > 0 > balance Sheet > cash
83394000
Quarters > 0 > balance Sheet > short Term Investments
164916000
Quarters > 0 > balance Sheet > receivables
10837000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
272437000
Quarters > 0 > balance Sheet > property Plant Equipment
6791000
Quarters > 0 > balance Sheet > total Assets
360264000
Quarters > 0 > balance Sheet > payables
5871000
Quarters > 0 > balance Sheet > short Term Debt
2908000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
52159000
Quarters > 0 > balance Sheet > equity
308105000
Quarters > 0 > cash Flow > net Income
-38347000
Quarters > 0 > cash Flow > depreciation
989000
Quarters > 0 > cash Flow > change In Working Capital
-1119000
Quarters > 0 > cash Flow > cash From Operations
-30366000
Quarters > 0 > cash Flow > capital Expenditures
132000
Quarters > 0 > cash Flow > cash From Investing
9094000
Quarters > 0 > cash Flow > cash From Financing
3120000
Quarters > 0 > cash Flow > net Change In Cash
-18153000
Quarters > 0 > ratios > PE
-0.6542552945550424
Quarters > 0 > ratios > PB
6.161640408399734
Quarters > 0 > ratios > ROE
-12.44608169292936
Quarters > 0 > ratios > ROA
-10.644138742699798
Quarters > 0 > ratios > FCF
-30498000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-2.868510158013544
Quarters > 0 > health Score
27
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
13817000
Quarters > 1 > income Statement > cost Of Revenue
1058000
Quarters > 1 > income Statement > gross Profit
13817000
Quarters > 1 > income Statement > operating Expenses
41117000
Quarters > 1 > income Statement > operating Income
-27300000
Quarters > 1 > income Statement > interest Expense
3000
Quarters > 1 > income Statement > pretax Income
-23483000
Quarters > 1 > income Statement > net Income
-23483000
Quarters > 1 > income Statement > eps
-0.4024241414727442
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
58353855
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-26854000
Quarters > 1 > income Statement > operating Margin
-197.58268799305202
Quarters > 1 > income Statement > total Other Income Expense Net
3817000
Quarters > 1 > balance Sheet > cash
101472000
Quarters > 1 > balance Sheet > short Term Investments
146236000
Quarters > 1 > balance Sheet > receivables
1622000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
269970000
Quarters > 1 > balance Sheet > property Plant Equipment
6561000
Quarters > 1 > balance Sheet > total Assets
384508000
Quarters > 1 > balance Sheet > payables
4313000
Quarters > 1 > balance Sheet > short Term Debt
2296000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
49565000
Quarters > 1 > balance Sheet > equity
334943000
Quarters > 1 > cash Flow > net Income
-23482000
Quarters > 1 > cash Flow > depreciation
446000
Quarters > 1 > cash Flow > change In Working Capital
-11123000
Quarters > 1 > cash Flow > cash From Operations
-25422000
Quarters > 1 > cash Flow > capital Expenditures
154000
Quarters > 1 > cash Flow > cash From Investing
-148477000
Quarters > 1 > cash Flow > cash From Financing
554000
Quarters > 1 > cash Flow > net Change In Cash
-173345000
Quarters > 1 > ratios > PE
-0.4024241414727442
Quarters > 1 > ratios > PB
5.642994071976426
Quarters > 1 > ratios > ROE
-7.011043670117005
Quarters > 1 > ratios > ROA
-6.107285154015001
Quarters > 1 > ratios > FCF
-25576000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-1.851053050589853
Quarters > 1 > health Score
29
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
158569000
Quarters > 2 > income Statement > cost Of Revenue
1076000
Quarters > 2 > income Statement > gross Profit
158569000
Quarters > 2 > income Statement > operating Expenses
47329000
Quarters > 2 > income Statement > operating Income
111240000
Quarters > 2 > income Statement > interest Expense
2889000
Quarters > 2 > income Statement > pretax Income
114157000
Quarters > 2 > income Statement > net Income
112879000
Quarters > 2 > income Statement > eps
1.9003646550592102
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
59398600
Quarters > 2 > income Statement > income Tax Expense
1278000
Quarters > 2 > income Statement > EBITDA
111717000
Quarters > 2 > income Statement > operating Margin
70.15242575787197
Quarters > 2 > income Statement > total Other Income Expense Net
2917000
Quarters > 2 > balance Sheet > cash
274817000
Quarters > 2 > balance Sheet > short Term Investments
82507000
Quarters > 2 > balance Sheet > receivables
606000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
375736000
Quarters > 2 > balance Sheet > property Plant Equipment
7442000
Quarters > 2 > balance Sheet > total Assets
406888000
Quarters > 2 > balance Sheet > payables
2186000
Quarters > 2 > balance Sheet > short Term Debt
2351000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
56814000
Quarters > 2 > balance Sheet > equity
350074000
Quarters > 2 > cash Flow > net Income
112879000
Quarters > 2 > cash Flow > depreciation
477000
Quarters > 2 > cash Flow > change In Working Capital
11613000
Quarters > 2 > cash Flow > cash From Operations
131827000
Quarters > 2 > cash Flow > capital Expenditures
152000
Quarters > 2 > cash Flow > cash From Investing
13632000
Quarters > 2 > cash Flow > cash From Financing
1374000
Quarters > 2 > cash Flow > net Change In Cash
146833000
Quarters > 2 > ratios > PE
1.9003646550592102
Quarters > 2 > ratios > PB
5.49575419482738
Quarters > 2 > ratios > ROE
32.24432548546879
Quarters > 2 > ratios > ROA
27.742032205422625
Quarters > 2 > ratios > FCF
131675000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.8303956006533434
Quarters > 2 > health Score
89
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
22614000
Quarters > 3 > income Statement > cost Of Revenue
1108000
Quarters > 3 > income Statement > gross Profit
22614000
Quarters > 3 > income Statement > operating Expenses
36267000
Quarters > 3 > income Statement > operating Income
-13653000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-10482000
Quarters > 3 > income Statement > net Income
-10482000
Quarters > 3 > income Statement > eps
-0.18380026995248197
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
57029296
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-13127000
Quarters > 3 > income Statement > operating Margin
-60.37410453701247
Quarters > 3 > income Statement > total Other Income Expense Net
3171000
Quarters > 3 > balance Sheet > cash
127983000
Quarters > 3 > balance Sheet > short Term Investments
88916000
Quarters > 3 > balance Sheet > receivables
700000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
232756000
Quarters > 3 > balance Sheet > property Plant Equipment
8254000
Quarters > 3 > balance Sheet > total Assets
271555000
Quarters > 3 > balance Sheet > payables
2498000
Quarters > 3 > balance Sheet > short Term Debt
2322000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
42534000
Quarters > 3 > balance Sheet > equity
229021000
Quarters > 3 > cash Flow > net Income
-10482000
Quarters > 3 > cash Flow > depreciation
526000
Quarters > 3 > cash Flow > change In Working Capital
-20176000
Quarters > 3 > cash Flow > cash From Operations
-23193000
Quarters > 3 > cash Flow > capital Expenditures
42000
Quarters > 3 > cash Flow > cash From Investing
819000
Quarters > 3 > cash Flow > cash From Financing
568000
Quarters > 3 > cash Flow > net Change In Cash
-21806000
Quarters > 3 > ratios > PE
-0.18380026995248197
Quarters > 3 > ratios > PB
8.065543759917214
Quarters > 3 > ratios > ROE
-4.576872863187218
Quarters > 3 > ratios > ROA
-3.859991530260905
Quarters > 3 > ratios > FCF
-23235000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-1.0274608649509154
Quarters > 3 > health Score
26
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
36555000
Annuals > 0 > income Statement > cost Of Revenue
4442000
Annuals > 0 > income Statement > gross Profit
36555000
Annuals > 0 > income Statement > operating Expenses
137927000
Annuals > 0 > income Statement > operating Income
-101372000
Annuals > 0 > income Statement > interest Expense
12638000
Annuals > 0 > income Statement > pretax Income
-88981000
Annuals > 0 > income Statement > net Income
-88981000
Annuals > 0 > income Statement > eps
-1.6475252783880014
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
54008883
Annuals > 0 > income Statement > income Tax Expense
-88981000
Annuals > 0 > income Statement > EBITDA
-99195000
Annuals > 0 > income Statement > operating Margin
-277.3136369853645
Annuals > 0 > income Statement > total Other Income Expense Net
12391000
Annuals > 0 > balance Sheet > cash
127983000
Annuals > 0 > balance Sheet > short Term Investments
88916000
Annuals > 0 > balance Sheet > receivables
700000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
232756000
Annuals > 0 > balance Sheet > property Plant Equipment
8254000
Annuals > 0 > balance Sheet > total Assets
271555000
Annuals > 0 > balance Sheet > payables
2498000
Annuals > 0 > balance Sheet > short Term Debt
2322000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
42534000
Annuals > 0 > balance Sheet > equity
229021000
Annuals > 0 > cash Flow > net Income
-88981000
Annuals > 0 > cash Flow > depreciation
2177000
Annuals > 0 > cash Flow > change In Working Capital
-28140000
Annuals > 0 > cash Flow > cash From Operations
-86851000
Annuals > 0 > cash Flow > capital Expenditures
203000
Annuals > 0 > cash Flow > cash From Investing
-107475000
Annuals > 0 > cash Flow > cash From Financing
131094000
Annuals > 0 > cash Flow > net Change In Cash
-63232000
Annuals > 0 > ratios > PE
-1.6475252783880014
Annuals > 0 > ratios > PB
7.301142767169823
Annuals > 0 > ratios > ROE
-38.8527689600517
Annuals > 0 > ratios > ROA
-32.76721106221576
Annuals > 0 > ratios > FCF
-87054000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-2.3814526056627
Annuals > 0 > health Score
26
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
8780000
Annuals > 1 > income Statement > cost Of Revenue
4729000
Annuals > 1 > income Statement > gross Profit
8780000
Annuals > 1 > income Statement > operating Expenses
123553000
Annuals > 1 > income Statement > operating Income
-114773000
Annuals > 1 > income Statement > interest Expense
9908000
Annuals > 1 > income Statement > pretax Income
-104699000
Annuals > 1 > income Statement > net Income
-104699000
Annuals > 1 > income Statement > eps
-2.37980062308185
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
43994862
Annuals > 1 > income Statement > income Tax Expense
4561105
Annuals > 1 > income Statement > EBITDA
-112304000
Annuals > 1 > income Statement > operating Margin
-1307.2095671981776
Annuals > 1 > income Statement > total Other Income Expense Net
10074000
Annuals > 1 > balance Sheet > cash
191442000
Annuals > 1 > balance Sheet > short Term Investments
9952000
Annuals > 1 > balance Sheet > receivables
64000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
215339000
Annuals > 1 > balance Sheet > property Plant Equipment
12434000
Annuals > 1 > balance Sheet > total Assets
228342000
Annuals > 1 > balance Sheet > payables
1695000
Annuals > 1 > balance Sheet > short Term Debt
2062000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
68777000
Annuals > 1 > balance Sheet > equity
159565000
Annuals > 1 > cash Flow > net Income
-104699000
Annuals > 1 > cash Flow > depreciation
2469000
Annuals > 1 > cash Flow > change In Working Capital
-6030000
Annuals > 1 > cash Flow > cash From Operations
-81067000
Annuals > 1 > cash Flow > capital Expenditures
1616000
Annuals > 1 > cash Flow > cash From Investing
105946000
Annuals > 1 > cash Flow > cash From Financing
53007000
Annuals > 1 > cash Flow > net Change In Cash
77886000
Annuals > 1 > ratios > PE
-2.37980062308185
Annuals > 1 > ratios > PB
8.536213627800583
Annuals > 1 > ratios > ROE
-65.61526650581267
Annuals > 1 > ratios > ROA
-45.85183628066672
Annuals > 1 > ratios > FCF
-82683000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-9.417198177676537
Annuals > 1 > health Score
27
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
12405000
Annuals > 2 > income Statement > cost Of Revenue
3535000
Annuals > 2 > income Statement > gross Profit
12405000
Annuals > 2 > income Statement > operating Expenses
116761000
Annuals > 2 > income Statement > operating Income
-104356000
Annuals > 2 > income Statement > interest Expense
3122000
Annuals > 2 > income Statement > pretax Income
-101067000
Annuals > 2 > income Statement > net Income
-93110000
Annuals > 2 > income Statement > eps
-2.393730672572248
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
38897442
Annuals > 2 > income Statement > income Tax Expense
-7957000
Annuals > 2 > income Statement > EBITDA
-102810000
Annuals > 2 > income Statement > operating Margin
-841.2414349052801
Annuals > 2 > income Statement > total Other Income Expense Net
3289000
Annuals > 2 > balance Sheet > cash
113556000
Annuals > 2 > balance Sheet > short Term Investments
116039000
Annuals > 2 > balance Sheet > receivables
588000
Annuals > 2 > balance Sheet > inventories
10932000
Annuals > 2 > balance Sheet > total Current Assets
244070000
Annuals > 2 > balance Sheet > property Plant Equipment
11428000
Annuals > 2 > balance Sheet > total Assets
256067000
Annuals > 2 > balance Sheet > payables
766000
Annuals > 2 > balance Sheet > short Term Debt
2359000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
71218000
Annuals > 2 > balance Sheet > equity
184849000
Annuals > 2 > cash Flow > net Income
-101067000
Annuals > 2 > cash Flow > depreciation
1546000
Annuals > 2 > cash Flow > change In Working Capital
43023000
Annuals > 2 > cash Flow > cash From Operations
-31866000
Annuals > 2 > cash Flow > capital Expenditures
3962000
Annuals > 2 > cash Flow > cash From Investing
-45882000
Annuals > 2 > cash Flow > cash From Financing
46409000
Annuals > 2 > cash Flow > net Change In Cash
-31339000
Annuals > 2 > ratios > PE
-2.393730672572248
Annuals > 2 > ratios > PB
6.514857014752582
Annuals > 2 > ratios > ROE
-50.370843228797554
Annuals > 2 > ratios > ROA
-36.36157724345581
Annuals > 2 > ratios > FCF
-35828000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-2.8881902458686013
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
3000000
Annuals > 3 > income Statement > cost Of Revenue
2230000
Annuals > 3 > income Statement > gross Profit
-2230000
Annuals > 3 > income Statement > operating Expenses
86065000
Annuals > 3 > income Statement > operating Income
-86065000
Annuals > 3 > income Statement > interest Expense
120000
Annuals > 3 > income Statement > pretax Income
-85805000
Annuals > 3 > income Statement > net Income
-84711000
Annuals > 3 > income Statement > eps
-2.3057344989634934
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
36739269
Annuals > 3 > income Statement > income Tax Expense
-1094000
Annuals > 3 > income Statement > EBITDA
-85091000
Annuals > 3 > income Statement > operating Margin
-2868.833333333333
Annuals > 3 > income Statement > total Other Income Expense Net
260000
Annuals > 3 > balance Sheet > cash
144895000
Annuals > 3 > balance Sheet > short Term Investments
74915000
Annuals > 3 > balance Sheet > receivables
132000
Annuals > 3 > balance Sheet > inventories
-74915000
Annuals > 3 > balance Sheet > total Current Assets
229218000
Annuals > 3 > balance Sheet > property Plant Equipment
9078000
Annuals > 3 > balance Sheet > total Assets
238865000
Annuals > 3 > balance Sheet > payables
2385000
Annuals > 3 > balance Sheet > short Term Debt
1507000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
21088000
Annuals > 3 > balance Sheet > equity
217777000
Annuals > 3 > cash Flow > net Income
-85805000
Annuals > 3 > cash Flow > depreciation
974000
Annuals > 3 > cash Flow > change In Working Capital
46000
Annuals > 3 > cash Flow > cash From Operations
-66907000
Annuals > 3 > cash Flow > capital Expenditures
1200000
Annuals > 3 > cash Flow > cash From Investing
-76426000
Annuals > 3 > cash Flow > cash From Financing
1284000
Annuals > 3 > cash Flow > net Change In Cash
-142049000
Annuals > 3 > ratios > PE
-2.3057344989634934
Annuals > 3 > ratios > PB
5.222993099546784
Annuals > 3 > ratios > ROE
-38.898047084862036
Annuals > 3 > ratios > ROA
-35.46396500115128
Annuals > 3 > ratios > FCF
-68107000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-22.702333333333332
Annuals > 3 > health Score
29
Valuation > metrics > PE
43.6056
Valuation > metrics > PB
6.161640408399734
Valuation > final Score
1
Valuation > verdict
89.9% Overvalued
Profitability > metrics > ROE
-12.44608169292936
Profitability > metrics > ROA
-14.075547741312672
Profitability > metrics > Net Margin
-3.606753197893153
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.1692896902030152
Risk > metrics > Interest Coverage
-14363.666666666666
Risk > final Score
-57395
Risk > verdict
High
Liquidity > metrics > Current Ratio
31.032805558719673
Liquidity > metrics > Quick Ratio
31.032805558719673
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
23.570059280235736
Prev Valuations > 1
45.0424580517262
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
100
Prev Profitabilities > 2
0
Prev Risks > 0
-36340
Prev Risks > 1
100
Prev Risks > 2
39
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:15:12.992Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-11
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.65
Earnings History > 0 > eps Estimate
-0.5805
Earnings History > 0 > eps Difference
-0.0695
Earnings History > 0 > surprise Percent
-11.9724
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.4
Earnings History > 1 > eps Estimate
-0.5
Earnings History > 1 > eps Difference
0.1
Earnings History > 1 > surprise Percent
20
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-05
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
1.9
Earnings History > 2 > eps Estimate
-0.0905
Earnings History > 2 > eps Difference
1.9905
Earnings History > 2 > surprise Percent
2199.4475
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-24
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.18
Earnings History > 3 > eps Estimate
-0.5302
Earnings History > 3 > eps Difference
0.3502
Earnings History > 3 > surprise Percent
66.0505
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-05
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.4691
Earnings History > 4 > eps Estimate
-0.53
Earnings History > 4 > eps Difference
0.0609
Earnings History > 4 > surprise Percent
11.4906
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-07
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.46
Earnings History > 5 > eps Estimate
-0.56
Earnings History > 5 > eps Difference
0.1
Earnings History > 5 > surprise Percent
17.8571
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-06
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.57
Earnings History > 6 > eps Estimate
-0.61
Earnings History > 6 > eps Difference
0.04
Earnings History > 6 > surprise Percent
6.5574
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-25
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.6
Earnings History > 7 > eps Estimate
-0.63
Earnings History > 7 > eps Difference
0.03
Earnings History > 7 > surprise Percent
4.7619
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-07
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.55
Earnings History > 8 > eps Estimate
-0.63
Earnings History > 8 > eps Difference
0.08
Earnings History > 8 > surprise Percent
12.6984
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-07
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.69
Earnings History > 9 > eps Estimate
-0.64
Earnings History > 9 > eps Difference
-0.05
Earnings History > 9 > surprise Percent
-7.8125
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-04
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.53
Earnings History > 10 > eps Estimate
-0.7
Earnings History > 10 > eps Difference
0.17
Earnings History > 10 > surprise Percent
24.2857
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-06
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.65
Earnings History > 11 > eps Estimate
-0.7
Earnings History > 11 > eps Difference
0.05
Earnings History > 11 > surprise Percent
7.1429
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.66
Earnings History > 12 > eps Estimate
-0.68
Earnings History > 12 > eps Difference
0.02
Earnings History > 12 > surprise Percent
2.9412
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-08
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.63
Earnings History > 13 > eps Estimate
-0.69
Earnings History > 13 > eps Difference
0.06
Earnings History > 13 > surprise Percent
8.6957
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-10
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.66
Earnings History > 14 > eps Estimate
0.36
Earnings History > 14 > eps Difference
-1.02
Earnings History > 14 > surprise Percent
-283.3333
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-10
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.66
Earnings History > 15 > eps Estimate
-0.62
Earnings History > 15 > eps Difference
-0.04
Earnings History > 15 > surprise Percent
-6.4516
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-08
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.61
Earnings History > 16 > eps Estimate
-0.59
Earnings History > 16 > eps Difference
-0.02
Earnings History > 16 > surprise Percent
-3.3898
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-10
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.6
Earnings History > 17 > eps Estimate
-0.47
Earnings History > 17 > eps Difference
-0.13
Earnings History > 17 > surprise Percent
-27.6596
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-10
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.46
Earnings History > 18 > eps Estimate
-0.44
Earnings History > 18 > eps Difference
-0.02
Earnings History > 18 > surprise Percent
-4.5455
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-09
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.42
Earnings History > 19 > eps Estimate
-0.42
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
0
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-12
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.41
Earnings History > 20 > eps Estimate
-0.41
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
0
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-10
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.39
Earnings History > 21 > eps Estimate
-0.35
Earnings History > 21 > eps Difference
-0.04
Earnings History > 21 > surprise Percent
-11.4286
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-15
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.34
Earnings History > 22 > eps Estimate
-0.36
Earnings History > 22 > eps Difference
0.02
Earnings History > 22 > surprise Percent
5.5556
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-02-23
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.09
Earnings History > 23 > eps Estimate
-0.31
Earnings History > 23 > eps Difference
0.22
Earnings History > 23 > surprise Percent
70.9677
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-12
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.26
Earnings History > 24 > eps Estimate
-0.27
Earnings History > 24 > eps Difference
0.01
Earnings History > 24 > surprise Percent
3.7037
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-14
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-1.54
Earnings History > 25 > eps Estimate
-0.96
Earnings History > 25 > eps Difference
-0.58
Earnings History > 25 > surprise Percent
-60.4167
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-06-19
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-6.89
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-6.89
Earnings History > 26 > surprise Percent
-
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy; and Zorevunersen (STK-001), an investigational new medicine for the treatment of Dravet syndrome is being evaluated in phase I/II clinical trials. The company also develops programs focused on various targets, including haploinsufficiency diseases of the central nervous system and eye. It has a license and collaboration with Biogen Inc. for the development and commercialization of zorevunersen medicine for the treatment of Dravet syndrome; and Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of genetic neurodevelopmental diseases. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AStoke Therapeutics (NASDAQ:STOK) Price Target Raised to $50.00 at HC Wainwright - MarketBeat
12/15/2025
Stoke Therapeutics (NASDAQ:STOK) Price Target Raised to $50.00 at HC Wainwright MarketBeat
Read more →STOK: HC Wainwright & Co. Raises Price Target to $50 | STOK Stoc GuruFocus
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$31.625
Analyst Picks
Strong Buy
7
Buy
2
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 124.32% of the total shares of Stoke Therapeutics Inc
1.
FMR Inc(13.528%)
since
2025/06/30
2.
BlackRock Inc(10.8118%)
since
2025/06/30
3.
RTW INVESTMENTS, LLC(9.3499%)
since
2025/06/30
4.
Baker Bros Advisors LP(8.4563%)
since
2025/06/30
5.
Redmile Group, LLC(7.9857%)
since
2025/06/30
6.
Morgan Stanley - Brokerage Accounts(6.5222%)
since
2025/06/30
7.
Skorpios Trust(5.9422%)
since
2025/06/30
8.
The Toronto-Dominion Bank(5.7909%)
since
2025/06/30
9.
Vanguard Group Inc(5.3766%)
since
2025/06/30
10.
Marshall Wace Asset Management Ltd(4.1983%)
since
2025/06/30
11.
Siren, L.L.C.(4.1012%)
since
2025/06/30
12.
Fidelity Select Biotechnology(2.8575%)
since
2025/07/31
13.
Vanguard Total Stock Mkt Idx Inv(2.8104%)
since
2025/07/31
14.
State Street Corp(2.7139%)
since
2025/06/30
15.
Goldman Sachs Group Inc(2.3749%)
since
2025/06/30
16.
Polar Capital Biotech S Inc(2.2811%)
since
2025/07/31
17.
Fidelity Select Health Care(2.1899%)
since
2025/07/31
18.
iShares Russell 2000 ETF(1.8107%)
since
2025/08/31
19.
Geode Capital Management, LLC(1.7755%)
since
2025/06/30
20.
Fidelity Stock Selector Small Cap(1.774%)
since
2025/06/30
21.
Polar Capital Holdings PLC(1.6126%)
since
2025/06/30
22.
FIAM Small Cap Core CIT Cl B(1.5895%)
since
2025/06/30
23.
BlackRock Health Sciences Opps Inv A(1.5643%)
since
2025/07/31
24.
BGF World Healthscience A2(1.5532%)
since
2025/05/31
25.
Fidelity Series Small Cap Opps(1.5262%)
since
2025/06/30
26.
MPM Oncology Impact Management LP(1.4411%)
since
2025/06/30
27.
Fidelity Advisor Biotechnology I(1.2988%)
since
2025/07/31
28.
Fidelity Advisor Health Care I(1.2592%)
since
2025/07/31
29.
Dimensional Fund Advisors, Inc.(1.2298%)
since
2025/06/30
30.
CI Private Wealth LLC(1.2041%)
since
2025/06/30
31.
SPDR® S&P Biotech ETF(1.1441%)
since
2025/08/31
32.
Opaleye Management Inc(1.0258%)
since
2025/06/30
33.
Bank of America Corp(1.0002%)
since
2025/06/30
34.
Vanguard Institutional Extnd Mkt Idx Tr(0.7992%)
since
2025/07/31
35.
Fidelity Small Cap Index(0.7528%)
since
2025/06/30
36.
iShares Russell 2000 Growth ETF(0.6508%)
since
2025/08/31
37.
BlackRock Health Sciences Term Trust(0.5641%)
since
2025/06/30
38.
Fidelity Series Small Cap Core(0.5254%)
since
2025/06/30
39.
Strategic Advisers Fidelity US TtlStk(0.465%)
since
2025/07/31
40.
iShares Biotechnology ETF(0.4627%)
since
2025/08/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.65
EPS Estimate
-0.5805
EPS Difference
-0.0695
Surprise Percent
-11.9724%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.